Top of page
Lawyers

Jie Zhang

Lawyers

Jie Zhang

Counsel - Registered Foreign Lawyer
Corporate
Beijing

Advises corporate and private equity clients on M&A, including pre-IPO financings, buyouts, JVs, PIPEs, de-SPAC, going-private transactions and strategic investments.

Jie is counsel in our Corporate practice, currently practicing as a Registered Foreign Lawyer in Beijing. Jie’s practice focuses on advising corporate clients and private equity funds on M&A matters, including pre-IPO financings, buyouts, joint ventures, PIPEs, de-SPAC transactions, going-private transactions and strategic investments. She also advises clients on securities law and general corporate matters.

Experience highlights

Mergers & Acquisitions
  • Provident Acquisition on the $1.02 billion combination with Perfect
  • The special committee on the going-private transaction of New Frontier Health
  • The special committee on the going-private transaction of 51job
  • UP Fintech on its $65 million convertible notes private placement
  • The special committee on the going-private transaction of China Biologic Products
  • Tencent on the going-private transaction of Sogou
  • Yintech on its going-private transaction
  • Tencent and Tencent Music Entertainment on the acquisition by a Tencent-led consortium of a 20% equity stake in Universal Music Group from Vivendi
  • Tencent on its investment in Tuhu
  • Comcast Spectacor on its T1 esports joint venture with SK Telecom
  • Unitas Capital’s sale of Jiahao Foods to Huabao International Holdings for approximately $694 million
  • iKang Healthcare on its acquisition by Yunfeng Capital and Alibaba
  • Tencent and Tencent Music Entertainment on their investments in Spotify, and on the cross-shareholding by Spotify in Tencent Music Entertainment
  • China Biologic Products on its acquisition of 80% equity interest in Tianxinfu for approximately $513 million
  • China Biologic Products redomiciles from Delaware to the Cayman Islands by its merging with and into its wholly owned subsidiary China Biologic Products
  • Tencent on its acquisition of China Music Corporation
  • Meituan Corporation on its strategic cooperation with DianPing
  • Special committee of Origin Agritech on its sale of commercial seed production and distribution business
  • China Biologic Products on its $590 million private placement
  • Sequoia on its various investments in pre-IPO companies, including Ke, Julive and Genesis Medtech
  • Megvii Technology on its pre-IPO financing
  • iQiyi on its $1.53 billion convertible notes financing
  • UCAR Technology on its $550 million Series B equity financing
  • IDG Capital Partners on its investment in SouFun
Capital Markets
  • Sinopec Group Overseas Development $3 billion senior notes offering
  • Hong Yang Group $125 million high-yield notes offering
  • Logan Property Holdings $200 and $450 million senior notes offerings
  • Shandong Yuhuang Chemical $300 million high-yield notes offering
  • China Aoyuan Property $250 Million high-yield notes offering
  • Toyota Motor Credit Corporation $750 million offering in Taiwan
  • Toyota Motor Credit Corporation $1.75 billion offering
View more experience

News

Education
J.D., Harvard Law School
  • cum laude
Ph.D., Cancer Biology, University of Chicago
B.S., Biological Sciences, Peking University
  • with high honors
Professional history
  • Counsel - Registered Foreign Lawyer, 2022-present
  • Registered Foreign Lawyer, 2014-2021
Qualifications and admissions
  • Beijing Ministry of Justice - Registered
  • State of New York
Back to top